VEA
CINC

Virtus ETF Advisers’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Virtus ETF Advisers’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,557
Closed -$142K – 505
2022
Q4 		$142K Buy
+11,557
New +$275K 0.07% 359

Virtus ETF Advisers's CINC Position: Q1 2023 in Review

Virtus ETF Advisers sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 11,557 shares — an estimated $142K sold.

Virtus ETF Advisers first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $142K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Virtus ETF Advisers reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Virtus ETF Advisers sold 11,557 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $142K.
  • Virtus ETF Advisers first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Virtus ETF Advisers's CinCor Pharma, Inc. Common Stock position peaked at $142K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Virtus ETF Advisers's 13F filing for Q1 2023, filed 15 May 2023.